However, emerging data and mechanistic plausibility suggest that certain populations may be at higher risk of suboptimal intake or depletion, particularly with prolonged therapy, rapid weight loss, restricted dietary variety or pre-existing marginal nutrient status
As we still have to wait for a further, wider review of GLP-1 RAs, one could argue that the guideline still feels behind the times in some areas, and that an opportunity is being missed for a potentially useful class of drugs.
When I did that anti-Christian comic, which I felt was really pretty sympathetic, I got letters from hardcore Christians who didnt agree with what I had to say
The FDA first announced two months ago that any shortage of the meds observed during the summer was over
It also pairs fasting glucose in the 100-125 mg/dL range with lower maintenance levels
Future Warnings Alison Cave, Chief Safety Officer of the MHRA, said: For the vast majority of patients who are prescribed GLP-1s, they are safe and effective medicines which deliver significant health benefits